Novo Nordisk has topped Pfizer’s offer for Metsera with a bid of up to US$9 billion, seeking to secure Metsera’s obesity-drug ...

Regeneron and ModeX Therapeutics have joined forces in a collaboration worth over one billion dollars to develop ...

In an era where chronic inflammatory diseases are taking centre stage in healthcare debates, the biologics segment is ...

Novartis will acquire Avidity Biosciences for about US$12 billion to gain its RNA platform and late-stage rare-disease ...

Boehringer Ingelheim licences a novel small-molecule treatment from Kyowa Kirin for fibro-inflammatory and autoimmune diseases in a deal worth up to €410 million.

CNX Therapeutics, a specialty pharmaceutical company, has been recognised with two prestigious industry awards during CPHI week in Frankfurt, marking three awards in two months for the London-based ...

Imlifidase successfully met primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation. First clinical data supports imlifidase ability to substantially reduce anti-AAV antibodies ...

Biotech company Pila Pharma has recently completed a strongly oversubscribed share issue on Nasdaq First North in Stockholm. The raised capital of nearly SEK 30 million will finance the first steps of ...

Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more ...

MAYFIELD, KY / ACCESS Newswire / October 29, 2025 / Genesis Medical Detox is proud to announce the opening of its newest ...

The auto injector market represents a rapidly expanding segment within the global pharmaceutical delivery systems industry, ...

Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation TherapyBOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana ...